vs
Side-by-side financial comparison of MAXLINEAR, INC (MXL) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.
MAXLINEAR, INC is the larger business by last-quarter revenue ($137.2M vs $83.1M, roughly 1.7× PROCEPT BioRobotics Corp). MAXLINEAR, INC runs the higher net margin — -32.9% vs -38.1%, a 5.2% gap on every dollar of revenue. On growth, MAXLINEAR, INC posted the faster year-over-year revenue change (43.0% vs 20.2%). Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (24.8% CAGR vs 22.1%).
MaxLinear, Inc. is an American electronic hardware company. Founded in 2003, it provides highly integrated radio-frequency (RF) analog and mixed-signal semiconductor products for broadband communications applications. It is a New York Stock Exchange-traded company.
PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.
MXL vs PRCT — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $137.2M | $83.1M |
| Net Profit | $-45.1M | $-31.6M |
| Gross Margin | 57.5% | 64.9% |
| Operating Margin | 30.0% | -4.1% |
| Net Margin | -32.9% | -38.1% |
| Revenue YoY | 43.0% | 20.2% |
| Net Profit YoY | -203.0% | -27.9% |
| EPS (diluted) | $-0.52 | $-0.56 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $137.2M | $83.1M | ||
| Q4 25 | $136.4M | $76.4M | ||
| Q3 25 | $126.5M | $83.3M | ||
| Q2 25 | $108.8M | $79.2M | ||
| Q1 25 | $95.9M | $69.2M | ||
| Q4 24 | $92.2M | $68.2M | ||
| Q3 24 | $81.1M | $58.4M | ||
| Q2 24 | $92.0M | $53.4M |
| Q1 26 | $-45.1M | $-31.6M | ||
| Q4 25 | $-14.9M | $-29.8M | ||
| Q3 25 | $-45.5M | $-21.4M | ||
| Q2 25 | $-26.6M | $-19.6M | ||
| Q1 25 | $-49.7M | $-24.7M | ||
| Q4 24 | $-57.8M | $-18.9M | ||
| Q3 24 | $-75.8M | $-21.0M | ||
| Q2 24 | $-39.3M | $-25.6M |
| Q1 26 | 57.5% | 64.9% | ||
| Q4 25 | 57.6% | 60.6% | ||
| Q3 25 | 56.9% | 64.8% | ||
| Q2 25 | 56.5% | 65.4% | ||
| Q1 25 | 56.1% | 63.9% | ||
| Q4 24 | 55.6% | 64.0% | ||
| Q3 24 | 54.4% | 63.2% | ||
| Q2 24 | 54.6% | 59.0% |
| Q1 26 | 30.0% | -4.1% | ||
| Q4 25 | -10.9% | -40.6% | ||
| Q3 25 | -32.7% | -27.8% | ||
| Q2 25 | -22.6% | -28.0% | ||
| Q1 25 | -48.0% | -39.7% | ||
| Q4 24 | -44.7% | -28.9% | ||
| Q3 24 | -82.3% | -38.4% | ||
| Q2 24 | -44.4% | -50.3% |
| Q1 26 | -32.9% | -38.1% | ||
| Q4 25 | -10.9% | -39.1% | ||
| Q3 25 | -36.0% | -25.7% | ||
| Q2 25 | -24.4% | -24.7% | ||
| Q1 25 | -51.8% | -35.8% | ||
| Q4 24 | -62.8% | -27.6% | ||
| Q3 24 | -93.4% | -35.9% | ||
| Q2 24 | -42.7% | -48.0% |
| Q1 26 | $-0.52 | $-0.56 | ||
| Q4 25 | $-0.17 | $-0.54 | ||
| Q3 25 | $-0.52 | $-0.38 | ||
| Q2 25 | $-0.31 | $-0.35 | ||
| Q1 25 | $-0.58 | $-0.45 | ||
| Q4 24 | $-0.68 | $-0.34 | ||
| Q3 24 | $-0.90 | $-0.40 | ||
| Q2 24 | $-0.47 | $-0.50 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $61.1M | $245.6M |
| Total DebtLower is stronger | $123.8M | $51.7M |
| Stockholders' EquityBook value | $454.2M | $347.7M |
| Total Assets | $771.3M | $487.1M |
| Debt / EquityLower = less leverage | 0.27× | 0.15× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $61.1M | $245.6M | ||
| Q4 25 | $72.8M | $286.5M | ||
| Q3 25 | $111.9M | $294.3M | ||
| Q2 25 | $108.6M | $302.7M | ||
| Q1 25 | $102.8M | $316.2M | ||
| Q4 24 | $118.6M | $333.7M | ||
| Q3 24 | $148.5M | $196.8M | ||
| Q2 24 | $185.1M | $214.1M |
| Q1 26 | $123.8M | $51.7M | ||
| Q4 25 | — | $51.6M | ||
| Q3 25 | — | $51.6M | ||
| Q2 25 | — | $51.5M | ||
| Q1 25 | — | $51.5M | ||
| Q4 24 | — | $51.5M | ||
| Q3 24 | — | $51.4M | ||
| Q2 24 | — | $51.4M |
| Q1 26 | $454.2M | $347.7M | ||
| Q4 25 | $451.9M | $365.9M | ||
| Q3 25 | $464.7M | $380.3M | ||
| Q2 25 | $488.3M | $385.8M | ||
| Q1 25 | $493.2M | $389.2M | ||
| Q4 24 | $516.3M | $402.2M | ||
| Q3 24 | $556.9M | $241.2M | ||
| Q2 24 | $617.3M | $251.8M |
| Q1 26 | $771.3M | $487.1M | ||
| Q4 25 | $796.4M | $508.1M | ||
| Q3 25 | $808.1M | $511.5M | ||
| Q2 25 | $863.7M | $513.1M | ||
| Q1 25 | $855.3M | $519.4M | ||
| Q4 24 | $864.6M | $534.0M | ||
| Q3 24 | $895.3M | $374.1M | ||
| Q2 24 | $973.2M | $374.4M |
| Q1 26 | 0.27× | 0.15× | ||
| Q4 25 | — | 0.14× | ||
| Q3 25 | — | 0.14× | ||
| Q2 25 | — | 0.13× | ||
| Q1 25 | — | 0.13× | ||
| Q4 24 | — | 0.13× | ||
| Q3 24 | — | 0.21× | ||
| Q2 24 | — | 0.20× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MXL
Segment breakdown not available.
PRCT
| Handpieces and other consumables | $43.0M | 52% |
| System sales and rentals | $23.4M | 28% |
| Other | $11.1M | 13% |
| Service | $5.6M | 7% |
